Biochemical results confirm that ALK1 is crucial for the anti-angiogenic activities of BMP-9 and suggest that mediators other than (or in addition to) SMAD1/5/8 may play a vital role in the pathogenesis of HHT2. The gene discussed is ACVRL1; the disease is telangiectasia, hereditary hemorrhagic, type 2.